Circulating Adiponectin Is Inversely Associated with Risk of Thyroid Cancer: In Vivo and in Vitro Studies
J. Clin. Endocrinol. Metab., Dec 2011; 96: E2023 - E2028.
[four normal thyroid tissue specimens
]
QKI-Mediated Alternative Splicing of the Histone Variant MacroH2A1 Regulates Cancer Cell Proliferation
Mol. Cell. Biol., Oct 2011; 31: 4244 - 4255.
[Breast Tissue RNA]
Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. J Mol Diagn. 2011 Sep;13(5):493-503.
[Tumor Tissue]
Inhibition of miR-193a Expression by Max and RXRa Activates K-Ras and PLAU to Mediate Distinct Aspects of Cellular Transformation
Cancer Res., Aug 2011; 71: 5144 - 5153.
[RNAs from colon adenocarcinomas
]
Comprehensive Human Cancer and Normal Tissue Products
OriGene has developed comprehensive human cancer and normal tissue products from its biorepository of over 140,000 high quality human tissues, which are banked under strict collection protocols and undergo rigorous quality control to ensure each source block’s unparalleled quality.
Collected from major US institutions under strict IRB and ethical consenting practices
Maintained in a monitored environment and bar-coded for tracking purposes
Each tissue source block includes following clinical information
TissueFocus Tissue Total RNA and Genomic DNA over 5,000 searchable RNA and DNA samples for immediate delivery. Some with matched cancer and normal RNA and DNA samples from same donors
TissueFocus Tissue Protein Lysate prepared from frozen OCT-embedded tissue samples and provided with a Western blot image of a beta-Actin monoclonal antibody
OriGene’s comprehensive tissue products provide researchers ready-to-use tools for their studies in biomarker discovery and validation, cancer drug target identification and validation, companion diagnostic assay development, and personalized medicine for cancer patient. Our current tissue products include: